DE19934799B4 - Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten - Google Patents
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten Download PDFInfo
- Publication number
- DE19934799B4 DE19934799B4 DE19934799A DE19934799A DE19934799B4 DE 19934799 B4 DE19934799 B4 DE 19934799B4 DE 19934799 A DE19934799 A DE 19934799A DE 19934799 A DE19934799 A DE 19934799A DE 19934799 B4 DE19934799 B4 DE 19934799B4
- Authority
- DE
- Germany
- Prior art keywords
- diyl
- optionally monosubstituted
- atoms
- compounds
- rings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 239000011159 matrix material Substances 0.000 title claims abstract description 23
- 239000004990 Smectic liquid crystal Substances 0.000 title claims abstract description 15
- -1 pyrimidine-2,5-diyl Chemical group 0.000 claims abstract description 79
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 239000004973 liquid crystal related substance Substances 0.000 claims abstract description 27
- 239000000126 substance Substances 0.000 claims abstract description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- 230000010287 polarization Effects 0.000 claims abstract description 4
- 230000002269 spontaneous effect Effects 0.000 claims abstract description 4
- 230000003098 cholesteric effect Effects 0.000 claims abstract description 3
- 238000000819 phase cycle Methods 0.000 claims abstract description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 claims 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims 1
- 125000005714 2,5- (1,3-dioxanylene) group Chemical group [H]C1([H])OC([H])([*:1])OC([H])([H])C1([H])[*:2] 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 description 13
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 10
- 230000007704 transition Effects 0.000 description 10
- ORXTXIBTYGTQIP-UHFFFAOYSA-N [4-[2-(4-hexylphenyl)pyrimidin-5-yl]phenyl] dodecanoate Chemical compound C1=CC(OC(=O)CCCCCCCCCCC)=CC=C1C1=CN=C(C=2C=CC(CCCCCC)=CC=2)N=C1 ORXTXIBTYGTQIP-UHFFFAOYSA-N 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- 239000004988 Nematic liquid crystal Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Chemical class FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 1
- HPSRFJMDYFTALY-UHFFFAOYSA-N 2,5-bis(4-hexylphenyl)pyridine Chemical compound C1=CC(CCCCCC)=CC=C1C1=CC=C(C=2C=CC(CCCCCC)=CC=2)N=C1 HPSRFJMDYFTALY-UHFFFAOYSA-N 0.000 description 1
- XYGUNTNTTDQAGL-UHFFFAOYSA-N 2-(4-decoxyphenyl)-5-octoxypyrimidine Chemical compound C1=CC(OCCCCCCCCCC)=CC=C1C1=NC=C(OCCCCCCCC)C=N1 XYGUNTNTTDQAGL-UHFFFAOYSA-N 0.000 description 1
- CZVGOAPQSLSDNN-UHFFFAOYSA-N 2-(4-decoxyphenyl)-5-octylpyrimidine Chemical compound C1=CC(OCCCCCCCCCC)=CC=C1C1=NC=C(CCCCCCCC)C=N1 CZVGOAPQSLSDNN-UHFFFAOYSA-N 0.000 description 1
- HOAGGFRICQSSLG-UHFFFAOYSA-N 2-(4-hexoxyphenyl)-5-octoxypyrimidine Chemical compound N1=CC(OCCCCCCCC)=CN=C1C1=CC=C(OCCCCCC)C=C1 HOAGGFRICQSSLG-UHFFFAOYSA-N 0.000 description 1
- ATZLPEPWPJQANQ-UHFFFAOYSA-N 2-(4-hexoxyphenyl)-5-octylpyrimidine Chemical compound N1=CC(CCCCCCCC)=CN=C1C1=CC=C(OCCCCCC)C=C1 ATZLPEPWPJQANQ-UHFFFAOYSA-N 0.000 description 1
- YSLLSTYBZAIXMY-UHFFFAOYSA-N 2-(4-octoxyphenyl)-5-octylpyrimidine Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1=NC=C(CCCCCCCC)C=N1 YSLLSTYBZAIXMY-UHFFFAOYSA-N 0.000 description 1
- VOBDITLHDLEDIA-UHFFFAOYSA-N 2-fluoro-3-(4-hexylphenyl)-6-(4-octoxyphenyl)pyridine Chemical compound C1=CC(OCCCCCCCC)=CC=C1C1=CC=C(C=2C=CC(CCCCCC)=CC=2)C(F)=N1 VOBDITLHDLEDIA-UHFFFAOYSA-N 0.000 description 1
- SERCOFRNFWNRSV-UHFFFAOYSA-N 2-fluoro-6-(4-nonylphenyl)-3-(4-pentylphenyl)pyridine Chemical compound C1=CC(CCCCCCCCC)=CC=C1C1=CC=C(C=2C=CC(CCCCC)=CC=2)C(F)=N1 SERCOFRNFWNRSV-UHFFFAOYSA-N 0.000 description 1
- 150000005756 2-fluoropyridines Chemical class 0.000 description 1
- PCZMPMVKEAGBQN-NDEPHWFRSA-N 5-decyl-2-[4-[(2s)-2-fluorodecoxy]phenyl]pyrimidine Chemical compound N1=CC(CCCCCCCCCC)=CN=C1C1=CC=C(OC[C@@H](F)CCCCCCCC)C=C1 PCZMPMVKEAGBQN-NDEPHWFRSA-N 0.000 description 1
- FXRWZEOASSMXQD-UHFFFAOYSA-N 5-nonylpyrimidine Chemical compound CCCCCCCCCC1=CN=CN=C1 FXRWZEOASSMXQD-UHFFFAOYSA-N 0.000 description 1
- UZDWZYRAVGMCCT-UHFFFAOYSA-N 5-octyl-2-[4-(4-propylphenyl)phenyl]pyrimidine Chemical compound N1=CC(CCCCCCCC)=CN=C1C1=CC=C(C=2C=CC(CCC)=CC=2)C=C1 UZDWZYRAVGMCCT-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- BTJOFNYAOSHHIV-UHFFFAOYSA-N [2-(4-octoxyphenyl)pyrimidin-5-yl] octyl carbonate Chemical compound N1=CC(OC(=O)OCCCCCCCC)=CN=C1C1=CC=C(OCCCCCCCC)C=C1 BTJOFNYAOSHHIV-UHFFFAOYSA-N 0.000 description 1
- CMXIWXHSTDZDIX-UHFFFAOYSA-N [4-(5-undecylpyrimidin-2-yl)phenyl] 5-butylthiophene-2-carboxylate Chemical compound N1=CC(CCCCCCCCCCC)=CN=C1C(C=C1)=CC=C1OC(=O)C1=CC=C(CCCC)S1 CMXIWXHSTDZDIX-UHFFFAOYSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000002783 friction material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 150000004867 thiadiazoles Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/345—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
- C09K19/3458—Uncondensed pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/02—Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
- C09K19/0225—Ferroelectric
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Liquid Crystal Substances (AREA)
- Pyridine Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934799A DE19934799B4 (de) | 1999-07-28 | 1999-07-28 | Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten |
| US09/626,217 US6482479B1 (en) | 1999-07-28 | 2000-07-26 | Active matrix displays having high contrast values |
| JP2000229237A JP2001081466A (ja) | 1999-07-28 | 2000-07-28 | 高いコントラスト値を有するアクティブマトリックスディスプレイ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934799A DE19934799B4 (de) | 1999-07-28 | 1999-07-28 | Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE19934799A1 DE19934799A1 (de) | 2001-02-01 |
| DE19934799B4 true DE19934799B4 (de) | 2008-01-24 |
Family
ID=7915941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19934799A Expired - Fee Related DE19934799B4 (de) | 1999-07-28 | 1999-07-28 | Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6482479B1 (enExample) |
| JP (1) | JP2001081466A (enExample) |
| DE (1) | DE19934799B4 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8410109B2 (en) | 2005-07-29 | 2013-04-02 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| US8889698B2 (en) | 2007-02-01 | 2014-11-18 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19825488A1 (de) * | 1998-06-08 | 1999-12-09 | Aventis Res & Tech Gmbh & Co | Monostabiles ferroelektrisches Aktivmatrix-Display |
| DE19857352A1 (de) * | 1998-12-11 | 2000-06-15 | Clariant Gmbh | Ferroelektrische Aktivmatrix-Displays mit weitem Arbeitstemperaturbereich |
| US6824707B2 (en) | 2001-10-23 | 2004-11-30 | Clariant International Ltd. | Active matrix liquid crystal device and smectic liquid crystal mixture |
| EP1367114A1 (en) * | 2002-04-11 | 2003-12-03 | Clariant International Ltd. | Active matrix liquid crystal device and smectic liquid crystal mixture |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US7582635B2 (en) | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
| CN1314999C (zh) * | 2003-03-21 | 2007-05-09 | Lg.菲利浦Lcd株式会社 | 采用双背光单元的双液晶显示装置 |
| MX2007003321A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
| JP5149009B2 (ja) | 2004-09-20 | 2013-02-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体 |
| EP2289510A1 (en) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| JP4958786B2 (ja) | 2004-09-20 | 2012-06-20 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環誘導体および治療薬としてのそれらの使用 |
| US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| CN101084207A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
| AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| US20080167321A1 (en) * | 2004-09-20 | 2008-07-10 | Xenon Pharmaceuticals Inc. | Pyridine Derivatives For Inhibiting Human Stearoyl-Coa-Desaturase |
| EP2332527A3 (en) | 2004-10-20 | 2011-11-16 | Resverlogix Corp. | Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases |
| CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
| EP2233470B1 (en) * | 2005-07-04 | 2011-12-07 | High Point Pharmaceuticals, LLC | Histamine H3 receptor antagonists |
| JP4822432B2 (ja) * | 2006-07-25 | 2011-11-24 | 日東電工株式会社 | 液晶パネル、及び液晶表示装置 |
| JP2008102471A (ja) * | 2006-09-21 | 2008-05-01 | Nitto Denko Corp | 液晶パネル、及び液晶表示装置 |
| TWI362930B (en) | 2007-04-27 | 2012-05-01 | Purdue Pharma Lp | Trpv1 antagonists and uses thereof |
| CA2685121A1 (en) | 2007-04-27 | 2008-11-06 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| WO2009158404A1 (en) | 2008-06-26 | 2009-12-30 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| US8759362B2 (en) | 2008-10-24 | 2014-06-24 | Purdue Pharma L.P. | Bicycloheteroaryl compounds and their use as TRPV1 ligands |
| US8703962B2 (en) | 2008-10-24 | 2014-04-22 | Purdue Pharma L.P. | Monocyclic compounds and their use as TRPV1 ligands |
| WO2010079431A2 (en) | 2009-01-08 | 2010-07-15 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| KR101803259B1 (ko) | 2009-03-18 | 2017-11-30 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| CN107252429B (zh) | 2009-04-22 | 2023-06-16 | 雷斯韦洛吉克斯公司 | 新抗炎剂 |
| CA2798610A1 (en) | 2010-05-06 | 2011-11-10 | Bristol-Myers Squibb Company | Bicyclic heteroaryl compounds as gpr119 modulators |
| MX354015B (es) | 2011-06-22 | 2018-02-08 | Shionogi & Co | Antagonistas de trpv1 que incluyen sustituyentes dihidroxi y sus usos. |
| WO2013021276A1 (en) | 2011-08-10 | 2013-02-14 | Purdue Pharma L.P. | Trpv1 antagonists including dihydroxy substituent and uses thereof |
| CN102645784B (zh) * | 2011-10-21 | 2015-04-08 | 京东方科技集团股份有限公司 | 半透半反液晶显示面板及液晶显示器 |
| DK2773354T3 (da) | 2011-11-01 | 2019-08-05 | Resverlogix Corp | Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner |
| CN103666482B (zh) * | 2012-09-10 | 2016-05-25 | 苏州汉朗光电有限公司 | 一种近晶a相液晶材料 |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| KR102662814B1 (ko) | 2015-03-13 | 2024-05-03 | 리스버로직스 코퍼레이션 | 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법 |
| CN109097067B (zh) * | 2017-06-20 | 2021-12-21 | 江苏和成显示科技有限公司 | 液晶组合物及其在液晶显示器件中应用 |
| JP6979895B2 (ja) * | 2018-02-05 | 2021-12-15 | 東ソー株式会社 | チアゾール化合物及びその製造方法 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CA3171648A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds |
| PL4323362T3 (pl) | 2021-04-16 | 2025-08-18 | Gilead Sciences, Inc. | Sposoby wytwarzania karbanukleozydów z zastosowaniem amidów |
| AU2022328698B2 (en) | 2021-08-18 | 2025-02-20 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3807862A1 (de) * | 1988-03-10 | 1989-09-21 | Merck Patent Gmbh | Smektische fluessigkristallphase |
| EP0427195A2 (en) * | 1989-11-07 | 1991-05-15 | Chisso Corporation | A ferroelectric liquid crystal composition |
| WO1997004039A1 (en) * | 1995-07-17 | 1997-02-06 | Hoechst Research & Technology Deutschland Gmbh & Co. Kg | Ferroelectric liquid crystal mixture |
| DE19830203A1 (de) * | 1998-07-07 | 2000-01-13 | Aventis Res & Tech Gmbh & Co | Monostabiles ferroelektrisches Aktivmatrix-Display |
| DE19922723A1 (de) * | 1999-05-18 | 2000-11-23 | Clariant Gmbh | Aktivmatrix-Displays mit hohem Kontrast |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4367924A (en) | 1980-01-08 | 1983-01-11 | Clark Noel A | Chiral smectic C or H liquid crystal electro-optical device |
| DE3068983D1 (en) | 1980-01-10 | 1984-09-27 | Noel A Clark | Chiral smectic liquid crystal electro-optical device and process of making the same |
| JP3132840B2 (ja) * | 1991-03-22 | 2001-02-05 | コニカ株式会社 | 感熱転写記録用受像シートおよび感熱転写記録方法 |
| JPH1025477A (ja) * | 1996-07-09 | 1998-01-27 | Mitsubishi Gas Chem Co Inc | フェリ誘電性液晶組成物 |
| DE19857352A1 (de) * | 1998-12-11 | 2000-06-15 | Clariant Gmbh | Ferroelektrische Aktivmatrix-Displays mit weitem Arbeitstemperaturbereich |
| JP4272733B2 (ja) * | 1998-12-25 | 2009-06-03 | キヤノン株式会社 | 液晶組成物 |
| JP2000319658A (ja) * | 1999-04-30 | 2000-11-21 | Sony Corp | 単安定強誘電液晶表示装置 |
| JP2000336361A (ja) * | 1999-05-31 | 2000-12-05 | Sony Corp | 単安定強誘電液晶表示装置 |
| DE19934798A1 (de) * | 1999-07-28 | 2001-02-01 | Clariant Gmbh | Smektische Flüssigkristallschalt- oder Anzeigevorrichtung mit hohem Kontrast |
-
1999
- 1999-07-28 DE DE19934799A patent/DE19934799B4/de not_active Expired - Fee Related
-
2000
- 2000-07-26 US US09/626,217 patent/US6482479B1/en not_active Expired - Lifetime
- 2000-07-28 JP JP2000229237A patent/JP2001081466A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3807862A1 (de) * | 1988-03-10 | 1989-09-21 | Merck Patent Gmbh | Smektische fluessigkristallphase |
| EP0427195A2 (en) * | 1989-11-07 | 1991-05-15 | Chisso Corporation | A ferroelectric liquid crystal composition |
| WO1997004039A1 (en) * | 1995-07-17 | 1997-02-06 | Hoechst Research & Technology Deutschland Gmbh & Co. Kg | Ferroelectric liquid crystal mixture |
| DE19830203A1 (de) * | 1998-07-07 | 2000-01-13 | Aventis Res & Tech Gmbh & Co | Monostabiles ferroelektrisches Aktivmatrix-Display |
| DE19922723A1 (de) * | 1999-05-18 | 2000-11-23 | Clariant Gmbh | Aktivmatrix-Displays mit hohem Kontrast |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8410109B2 (en) | 2005-07-29 | 2013-04-02 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| US8889698B2 (en) | 2007-02-01 | 2014-11-18 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001081466A (ja) | 2001-03-27 |
| US6482479B1 (en) | 2002-11-19 |
| DE19934799A1 (de) | 2001-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19934799B4 (de) | Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten | |
| DE69426358T2 (de) | Verbindungen zur verwendung in flüssigkristallzusammensetzungen | |
| EP1147162B1 (de) | Ferroelektrische aktivmatrix-displays mit weitem arbeitstemperaturbereich | |
| EP1198537B1 (de) | Aktivmatrix-displays mit hohem kontrast | |
| DE69416057T2 (de) | Mesomorphe Verbindung, eine diese enthaltene Flüssigkristallzusammensetzung, eine diese Zusammensetzung verwendende Flüssigkristallvorrichtung, Flüssigkristallapparat und Anzeigeverfahren | |
| DE68905884T2 (de) | Ferroelektrische, chirale, smektische fluessigkristall-zusammensetzung und vorrichtung zu deren anwendung. | |
| EP0620263B1 (de) | Smektische Flüssigkristallmischung | |
| EP0620262B1 (de) | Smektische Flüssigkristallmischung | |
| DE3709549A1 (de) | Verwendung von 5-phenyl-pyrimidinderivaten als komponenten in smektischen fluessigkristallmischungen | |
| DE10101021A1 (de) | Mehrfach fluorierte Fluorene und ihre Verwendung in Flüssigkristallmischungen | |
| DE4030579A1 (de) | Cyclohexylphenylpyrimidine, verfahren zu ihrer herstellung und ihre verwendung in fluessigkristallinen mischungen | |
| DE4143139A1 (de) | Chirale oxiranylmethyl-ether und ihre verwendung als dotierstoffe in fluessigkristallmischungen | |
| EP1086194B1 (de) | Monostabiles ferroelektrisches aktivmatrix-display | |
| EP1017757B1 (de) | Ferroelektrische flüssigkristallanzeige mit aktiven matrix elementen | |
| EP1086193B1 (de) | Monostabiles ferroelektrisches aktivmatrix-display | |
| DE69115377T2 (de) | Fluorierte Pyrimidin-Phenyl optisch aktive Verbindungen und sie enthaltende flüssigkristalline Zusammensetzungen | |
| DE68920919T2 (de) | Ferroelektrische chirale smektische Flüssigkristallzusammensetzung und Vorrichtung mit dieser Zusammensetzung. | |
| WO1999064925A1 (de) | Monostabiles ferroelektrisches aktivmatrix-display | |
| DE19830203A1 (de) | Monostabiles ferroelektrisches Aktivmatrix-Display | |
| DE3909355A1 (de) | Ferroelektrische fluessigkristalline mischungen | |
| EP0464072A1 (de) | Flüssigkristalline, insbesondere ferroelektrische flüssigkristalline mischungen. | |
| DE19825484A1 (de) | Monostabiles ferroelektrisches Aktivmatrix-Display | |
| EP1166175A1 (de) | Ferroelektrische flüssigkristallanzeige mit aktiven matrix elementen und unsymmetrischen orientierungsschichten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: AZ ELECTRONIC MATERIALS (GERMANY) GMBH, 65203 , DE |
|
| 8364 | No opposition during term of opposition | ||
| R081 | Change of applicant/patentee |
Owner name: MERCK PATENT GMBH, DE Free format text: FORMER OWNER: AZ ELECTRONIC MATERIALS (GERMANY) GMBH, 65203 WIESBADEN, DE |
|
| R082 | Change of representative |
Representative=s name: PATENTANWAELTE ISENBRUCK BOESL HOERSCHLER LLP, DE |
|
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |